| SENTINEL ONCOLOGY LIMITED Patent applications |
| Patent application number | Title | Published |
|---|
| 20130065900 | PHARMACEUTICAL COMPOUNDS - The invention provides a compound of the formula (1): | 03-14-2013 |
| 20120071478 | SUBSTITUTED BENZOTRIAZINES AND QUINOXALINES AS INHIBITORS OF P7OS6 KINASE - The invention provides compounds of the formula (1): | 03-22-2012 |
| 20110130394 | PHARMACEUTICAL COMPOUNDS - The invention provides kinase inhibitor compounds of the formula (1): | 06-02-2011 |
| 20100048540 | Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors - The invention relates to novel heterocyclic N-oxides which are useful as hypoxic selective cytotoxic agents that mediate and/or inhibit cell proliferation, for example, through the activity of protein kinases. The invention is further related to pharmaceutical compositions containing such compounds and compositions, and to methods of treating cancer as well as other disease states associated with unwanted ahgiogenesis and/or cellular proliferation by administering effective amounts of such compounds. | 02-25-2010 |
| 20090270416 | N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCER - The invention provides a Chk-1 kinase inhibiting compound of the formula (I) or a salt, solvate or tautomer thereof, wherein: G is CH | 10-29-2009 |
| 20080234276 | Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors - The invention relates to novel heterocyclic triazines which are useful as hypoxic selective cytotoxic agents that mediate and/or inhibit cell proliferation, for example, through the activity of protein kinases. The invention is further related to pharmaceutical compositions containing such compounds and compositions, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation by administering effective amounts of such compounds. | 09-25-2008 |
